A novel approach to advanced carcinoma of the tongue: cases successfully treated with combination of superselective intra-arterial chemotherapy and external/high-dose-rate interstitial radiotherapy

Jpn J Clin Oncol. 2006 Dec;36(12):822-6. doi: 10.1093/jjco/hyl111. Epub 2006 Oct 23.

Abstract

Objective: This study sought to evaluate the efficacy and safety of a novel treatment regimen, intra-arterial cisplatin infusion plus external/high-dose-rate radiotherapy.

Methods: Superselective intra-arterial infusion of cisplatin (100-120 mg) was performed concomitantly with external radiotherapy in four patients with locally advanced carcinoma of the tongue. A high-dose-rate brachytherapy boost was performed after combination therapy in all patients. Brachytherapy was performed after external radiotherapy, and the treatment schedule was twice daily, with a fraction of 600 cGy up to a total of 30-48 Gy.

Results: All patients completed the therapy as scheduled. There were no vascular or neurological complications. Grade III acute radiation mucositis developed in all patients but this did not necessitate a treatment break. With a mean follow-up period of 35 months, loco-regional control was obtained for all patients.

Conclusions: The combination of weekly administration of intra-arterial cisplatin plus external/high-dose-rate radiotherapy seems effective for advanced carcinoma of the tongue.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Adenocarcinoma / radiotherapy*
  • Adenocarcinoma / secondary
  • Adult
  • Aged
  • Antineoplastic Agents / administration & dosage*
  • Brachytherapy*
  • Cisplatin / administration & dosage*
  • Combined Modality Therapy
  • Female
  • Follow-Up Studies
  • Humans
  • Infusions, Intra-Arterial
  • Male
  • Neoplasm Staging
  • Survival Rate
  • Tongue Neoplasms / drug therapy*
  • Tongue Neoplasms / pathology
  • Tongue Neoplasms / radiotherapy*

Substances

  • Antineoplastic Agents
  • Cisplatin